TAO Synergies Inc.TAOX

$3.67-0.17 (-4.43%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$28M
Micro-cap
+485%
2025 — today
10-Year Price
+5%
2025 — today
52-Week Range
$3.35$10.38
Current $3.67· 5%

TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.

Valuation in context

P/E ratio
-0.3
N/A
Not meaningful — company is unprofitable
P/B ratio
1.1
Below average
Below the 10-year average
FCF Yield
-21.5%
Above average
Above the 10-year average
Free · No credit card needed

Get alerted when TAOX is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.